215 related articles for article (PubMed ID: 27757838)
1. Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.
Aziz F; Gao W; Yan Q
Pathol Oncol Res; 2017 Jan; 23(1):173-179. PubMed ID: 27757838
[TBL] [Abstract][Full Text] [Related]
2. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer.
Aziz F; Khan I; Shukla S; Dey DK; Yan Q; Chakraborty A; Yoshitomi H; Hwang SK; Sonwal S; Lee H; Haldorai Y; Xiao J; Huh YS; Bajpai VK; Han YK
Pharmacol Ther; 2022 Apr; 232():107994. PubMed ID: 34571111
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions.
Aziz F; Wang X; Liu J; Yan Q
Toxicol In Vitro; 2016 Mar; 31():158-66. PubMed ID: 26427350
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of LeY and fucosyltransferase IV correlates with the receptivity of RL95-2 and HEC-1A human uterine epithelial cells.
Liu S; Yang X; Wang J; Wei J; Zhang D; Wang X; Yan Q
Cell Biol Int; 2012 May; 36(5):469-74. PubMed ID: 22145955
[TBL] [Abstract][Full Text] [Related]
5. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Aziz F; Yang X; Wang X; Yan Q
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
[TBL] [Abstract][Full Text] [Related]
6. The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer.
Aziz F; Qiu Y
Curr Drug Targets; 2014 Apr; 15(4):469-76. PubMed ID: 24533777
[TBL] [Abstract][Full Text] [Related]
7. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori vacA and cagA genotype diversity and interferon gamma expression in patients with chronic gastritis and patients with gastric cancer.
Martínez-Carrillo DN; Atrisco-Morales J; Hernández-Pando R; Reyes-Navarrete S; Betancourt-Linares R; Cruz-del Carmen I; Illades Aguiar B; Román-Román A; Fernández-Tilapa G
Rev Gastroenterol Mex; 2014; 79(4):220-8. PubMed ID: 25432406
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis and distribution of Lewis X- and Lewis Y-containing glycoproteins in the murine male reproductive system.
Wang C; Huang C; Gu Y; Zhou Y; Zhu Z; Zhang Y
Glycobiology; 2011 Feb; 21(2):225-34. PubMed ID: 20876654
[TBL] [Abstract][Full Text] [Related]
11. Expression of Lewis antigens and their precursors in gastric mucosa: relationship with Helicobacter pylori infection and gastric carcinogenesis.
Lee HS; Choe G; Kim WH; Kim HH; Song J; Park KU
J Pathol; 2006 May; 209(1):88-94. PubMed ID: 16456898
[TBL] [Abstract][Full Text] [Related]
12. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
Miehlke S; Kirsch C; Agha-Amiri K; Günther T; Lehn N; Malfertheiner P; Stolte M; Ehninger G; Bayerdörffer E
Int J Cancer; 2000 Aug; 87(3):322-7. PubMed ID: 10897035
[TBL] [Abstract][Full Text] [Related]
13. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.
Mattar R; dos Santos AF; Eisig JN; Rodrigues TN; Silva FM; Lupinacci RM; Iriya K; Carrilho FJ
Helicobacter; 2005 Dec; 10(6):601-8. PubMed ID: 16302986
[TBL] [Abstract][Full Text] [Related]
14. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370.
Feng Y; Wang L; Zeng J; Shen L; Liang X; Yu H; Liu S; Liu Z; Sun Y; Li W; Chen C; Jia J
Mol Cancer Res; 2013 Aug; 11(8):834-44. PubMed ID: 23576572
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MUC5AC production and deposition of LEWIS determinants by HELICOBACTER PYLORI facilitate gastric tissue colonization and the maintenance of infection.
Gonciarz W; Walencka M; Moran AP; Hinc K; Obuchowski M; Chmiela M
J Biomed Sci; 2019 Mar; 26(1):23. PubMed ID: 30841890
[TBL] [Abstract][Full Text] [Related]
16. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases.
Marques T; David L; Reis C; Nogueira A
Pathol Res Pract; 2005; 201(10):665-72. PubMed ID: 16325508
[TBL] [Abstract][Full Text] [Related]
17. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.
Al-Marhoon MS; Nunn S; Soames RW
J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways.
Yang XS; Liu S; Liu YJ; Liu JW; Liu TJ; Wang XQ; Yan Q
J Cell Physiol; 2010 Nov; 225(2):612-9. PubMed ID: 20506505
[TBL] [Abstract][Full Text] [Related]
19. Association of the CagA gene positive Helicobacter pylori and tissue levels of interleukin-17 and interleukin-8 in gastric ulcer patients.
El-Fakhry AA; El-Daker MA; Badr RI; El-Nady GM; Mesbah MR; Youssef T; Arafa M; Arafa M; El-Naggar MM
Egypt J Immunol; 2012; 19(1):51-62. PubMed ID: 23888551
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori virulence markers in gastroduodenal disorders. Detection of cytotoxin-associated gene A and vacuolating cytotoxin-associated gene A genes in Saudi patients.
Al-Khattaf AS
Saudi Med J; 2012 Jul; 33(7):716-21. PubMed ID: 22821304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
